Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: Rheumatoid Arthritis is a systemic autoimmune disease leading to chronic progressive damage and significant disability, which also increases the cardiovascular risk by comparison to the general population. The aim of this study was to determine the association between treatments and cardiovascular risk. Methods: Ccross sectional study that included 70 subjects diagnosed with rheumatoid arthritis, with an age range 25 to 84 year-old. Patients, who met the inclusion criteria were assessed the cardiovascular risk using QRISK–2 score. Disease activity was assessed by using DAS-28 for each type of treatment. Results: Patients from both hospitals, Carlos Andrade Marín and Enrique Garcés had similar demographic data. Most chosen patients were in remission of their disease and only a a few had rheumatic activity. There was not association between rheumatic activity, assessed by DAS -28, and Cardiovascular Risk, measured by QRISK–2. Though, we found a singnificant association between treatment (DMARD + corticoid + AINE´s) with Low-Cardiovascular risk in hospital patients (OR: 5.9; 95%CI: 1.1, 33.2). Discusion: There were significant differences between the type of treatment and the cardiovascular risk. No association was found between cardiovascular risk and inflammation, though, theres was a strong relationship with age, (>65 years-old), education level and comorbidities.
Englund M, Joud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed
biologics. Rheumatology. 2010;49(8):1563-9.
Jeffery RC. Clinical features of rheumatoid arthritis. Medicine. 2014;42(5):231-6.
Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology: Expert
Consult-Online: Elsevier Health Sciences; 2014.
Arnab B, Biswadip G, Arindam P, Shyamash M, Anirban G, Rajan P. Anti-CCP antibody in
patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile? Journal of cardiovascular disease research. 2013;4(2):102-6
Amaya-Amaya J, Montoya-Sanchez L, Rojas- Villarraga A. Cardiovascular involvement in autoimmune diseases. BioMed research international. 2014;2014:367359.
Bartoloni E, Alunno A, Bistoni O, Gerli R. How early is the atherosclerotic risk in rheumatoid arthritis? Autoimmunity reviews. 2010;9(10):701-7
Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP, editors. Autonomic function and rheumatoid arthritis—A systematic review. Seminars in arthritis and rheumatism; 2014: Elsevier.
Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, et al. Rheumatoid arthritis and risk of acute myocardial infarction—a nationwide retrospective cohort study. International journal
Gerszten RE, Tager AM. The Monocyte in Atherosclerosis—Should I Stay or Should I Go Now? New England Journal of Medicine. 2012;366(18):1734-6
Firestein GS, Budd R, Gabriel SE, O’Dell JR, McInnes IB. Kelley’s Textbook of Rheuatology: Expert Consult Premium Edition: Enhanced Online Features: Elsevier Health Sciences; 2012.
Deane KD, Norris JM, Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigarion. Rheumatic diseases clinics of North America. 2010;36(2):213-41.
Keeling SO, Teo M, Fung D. Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clinical rheumatology. 2011;30(10):1311-7.
Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidencebased recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the rheumatic diseases. 2010;69(2):325-31.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting
cardiovascular risk in England and Wales: prospective derivarion and validation of QRISK2. Bmj. 2008;336(7659):1475-82.
Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Diaz C, Anaya JM, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. Arthritis. 2012;2012:371909.
Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, et AL. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Revista Panamericana de Salud Pública. 2012;32(2):131-9.
Núñez L, Marrugat J, Mujica V, Escobar MC, Jiménez AL, Pérez P, et al. Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adaptada para la población chilena. Revista médica de Chile. 2009;137(10):1273-82.
Collins GS, Altman DG. Predicting the 10 year rick of cardiovascular disease in the United Kingdom: indepedent and external validation of an updated versión of QRISK2. Bmj 2012;344:e4181.
Molina ABA, Guerrero MAS, Palacios MdCO, Reyes FM. Riesgo cardiovascular en pacientes diagnosticados de Artritis Reumatoide.
Gaujoux-Viala C, Gossec L, Cantagrel A, Dougados M, Fautrel B, Mariette X, et al. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. Joint, bone, spine : revue du rhumatisme. 2014;81(4):287-97.
Cardiel MH, Díaz-Borjón A, del Mercado Espinosa MV, Gámez-Nava JI, Fabris LAB, Tena CP, et al. Update of the Mexican college of rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis. Reumatología Clínica (English Edition). 2014;10(4):227-40.
Gaujoux-Viala C, Gossec L, Cantagrel A, Dougados M, Fautrel B, Mariette X, et al. Recomendations of the French Society for Rheumatology for managing rhematoid arthritis. Joint, bone, spine : revue du rhumatisme. 2014;81(4):287-97.
Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, et al. Nonsteroidal antiiflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation
;113(12):1578-87.
Nurmohamed MT. Cardiovascular risk in rheumatoid arthritis. Autoimmunity reviews. 2009;8(8):663-7.
Martire MV, Marino Claverie L, Duarte V, Secco A, Mammani M. Factors Associated With Sustained Remission in Patients With Rheumatoid Arthritis. Reumatología Clínica (English Edition). 2015(0).
van Staa T-P, Gulliford M, Ng ES-W, Goldacre B, Smeeth L. Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather tan Population Risk? PloS one. 214;9(10):e106455.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.